Your session is about to expire
← Back to Search
Chemoradiation for Glioblastoma (NeoGlio Trial)
NeoGlio Trial Summary
This trial is testing a new treatment for glioblastoma that has not been well studied before. The goal is to see if it improves local control, which is when the cancer comes back in the same area. If the new treatment is promising, there will be a bigger clinical trial testing it against the standard treatment.
NeoGlio Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNeoGlio Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NeoGlio Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant and willing to use birth control during the study.I am currently on IV antibiotics for a bacterial or fungal infection.I am able to care for myself but may not be able to do active work.My recent blood test shows I have enough white blood cells, platelets, and hemoglobin.I have been newly diagnosed with GBM confirmed by tissue analysis.I do not have liver problems causing jaundice or blood clotting issues.I am considered a good candidate for major surgery to remove my tumor.I have been recently diagnosed with GBM confirmed by tissue analysis.I am a candidate for major surgery as reviewed.My liver tests are within normal limits.I can safely receive chemoradiation.My hemoglobin level is at least 8.0 g/dl.I can safely receive chemoradiation.I am on dialysis or have been advised to start it due to end-stage kidney disease.My brain tumor has come back, can't be removed, or is in multiple places.I had a major heart attack in the last 6 months.I do not have a severe lung condition that requires hospital care right now.My recent blood test shows my bone marrow is working well.My cancer has spread from its original location.I have had treatment for brain or head and neck cancer but not with temozolomide.I was hospitalized for heart failure within the last 3 months.I have not had a heart attack in the last month.I haven't had serious wounds, ulcers, fractures, or major surgeries in the last 28 days, except for brain surgery.My liver is working well, as confirmed by recent tests.
- Group 1: Neoadjuvant chemoradiation and surgical resection
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has this therapeutic intervention been cleared by the Food and Drug Administration?
"Our team at Power judged the security of this treatment to be a 2 since it is still in Phase 2, which suggests that there are some safety data available but no evidence for efficacy."
Have any other research initiatives been conducted exploring this therapeutic method?
"Currently, 207 clinical trials are actively investigating this medication with 24 of these investigations having progressed to Phase 3. Interestingly, there is a large concentration of studies based in Seoul and Songpa; however, there exist 4752 other locations running similar research."
To what afflictions is this therapy normally administered?
"Nitrosourea treatment is the primary purpose of this medication, however it has also been successfully used to treat conditions such as advanced directives and refractory mycosis fungoides in addition torefractory neuroblastoma."
Does this experiment accept participants over 30 years of age?
"As per the inclusion criteria, those between 18 and 89 years of age are eligible to join this trial. 126 trials cater specifically for minors while 828 studies target seniors past 65."
Are there any opportunities for me to participate in this research initiative?
"The current trial has a recruitment target of 30 glioblastoma patients aged between 18 and 89. To qualify, these individuals should be deemed suitable for subtotal or gross resection by central review, with no contraindications to chemoradiation therapy."
What is the current enrollment threshold for this research?
"Affirmative. The details available on clinicaltrials.gov demonstrate that this research trial, which was first posted April 1st 2020, is currently seeking volunteers. Approximately 30 participants need to be sourced from 2 separate medical centers."
Does this trial mark a breakthrough in its field?
"Worldwide, 207 active clinical trials are ongoing for this specific treatment. These studies span 935 cities and 36 nations, beginning in 2002 when Schering-Plough conducted a Phase 2 trial involving 60 participants. From that point onward, 296 additional tests have been administered."
Are there currently spots open for this clinical trial?
"Per the data hosted on clinicaltrials.gov, this health study is currently recruiting patients. It was first listed in April 2020 and its information was most recently updated at the end of January 2022."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger